Newsletter | September 29, 2025

09.29.25 -- STREAM Edition: Dye Drug Conjugates For Cancer With Lahjavida's Lyle Small

SPONSOR

 

 

Connect with leading CDMOs as they present their available capacity, capabilities, locations, and timelines at the Small Molecule session of the Outsourced Pharma Capacity Update on Oct. 8. Through brief, interactive presentations, gain valuable insights and ask questions to find the right partner — all from your computer. This event is tailored for biopharma companies, consultants, and investors seeking CDMO collaborations for active therapeutic pipelines. Save your spot today!

Demonstrating Technical Excellence In Contract Manufacturing

Webinar | MilliporeSigma

Tech Talks explore ADC development innovations, including integrated supply chains, seamless pilot-to-GMP scale-ups, and advanced process analytical technology (PAT).

Identify And Quantify AAV Fill States Using Analytical Ultracentrifugation

Webinar | KBI Biopharma

Witness how sedimentation velocity analytical ultracentrifugation is being used to characterize AAV size distributions and multiple detection wavelengths to identify various fill states in AAV preparation.

Premier Packaging Challenges, Solutions For Emerging Innovators

Webinar | West Pharmaceutical Services, Inc.

If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.

Dye Drug Conjugates For Cancer With Lahjavida's Lyle Small

Video | Life Science Leader

On this week's Business Of Biotech episode, Lyle Small, Founder and CEO at Lahjavida, a dye drug conjugate start-up, talks about creating the famous color-changing technology that turned the mountains blue on cold Coors Light beer cans, to launching a dye-drug conjugate startup developing targeted cancer therapies.

How CRISPR And LNP Accelerate Therapeutic Innovation Through Analytics

Video | Cytiva

CRISPR gene editing and lipid nanoparticle delivery are revolutionizing precision medicine. Discover how optimized LNP systems and advanced analytics accelerate therapeutic development.

Nanoforming Biologics, GLP-1s: From I.V. To Sub Q And Inhaled Delivery

Webinar | Nanoform

By using nanoforming techniques, it's possible to simplify dosing regimens and enhance patient comfort, compliance, and even reduce overall healthcare costs.